Sunshine Biopharma and The Research Foundation of the State University of New York partnered to develop Sunshine's Adva-27a compound for cancer under a three-year research collaboration

Binghamton University

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Sunshine Biopharma Inc.

Canada / Small-Cap Biopharma (<$1 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced